Evelyn Mei Huang

Array ( [id] => 6651440 [patent_doc_number] => 20030105068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Organometallic complex' [patent_app_type] => new [patent_app_number] => 10/261130 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3148 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105068.pdf [firstpage_image] =>[orig_patent_app_number] => 10261130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6675029 [patent_doc_number] => 20030060632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Calcium channel blockers' [patent_app_type] => new [patent_app_number] => 10/252854 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29072 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060632.pdf [firstpage_image] =>[orig_patent_app_number] => 10252854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271816 [patent_doc_number] => 06653477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => 'Imidazopyridin-8-ones' [patent_app_type] => B2 [patent_app_number] => 10/182652 [patent_app_country] => US [patent_app_date] => 2002-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2500 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653477.pdf [firstpage_image] =>[orig_patent_app_number] => 10182652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660229 [patent_doc_number] => 20030134873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Adenosine receptor ligands' [patent_app_type] => new [patent_app_number] => 10/246551 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5602 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134873.pdf [firstpage_image] =>[orig_patent_app_number] => 10246551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073807 [patent_doc_number] => 06838472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Substituted urea retinoid agonists' [patent_app_type] => utility [patent_app_number] => 10/244885 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13926 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838472.pdf [firstpage_image] =>[orig_patent_app_number] => 10244885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856850 [patent_doc_number] => 20030130351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Liquid pharmaceutical compositions comprising thyroid hormones' [patent_app_type] => new [patent_app_number] => 10/243555 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2663 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130351.pdf [firstpage_image] =>[orig_patent_app_number] => 10243555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634670 [patent_doc_number] => 06656949 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => '4-anilinofuro 3,2-c quinoline derivatives, and preparation processes and uses of the same' [patent_app_type] => B1 [patent_app_number] => 10/241739 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3836 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656949.pdf [firstpage_image] =>[orig_patent_app_number] => 10241739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674879 [patent_doc_number] => 20030060482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Urease inhibitors' [patent_app_type] => new [patent_app_number] => 10/220803 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6542 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060482.pdf [firstpage_image] =>[orig_patent_app_number] => 10220803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6857016 [patent_doc_number] => 20030130517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Thienopyridine derivatives , their production and use' [patent_app_type] => new [patent_app_number] => 10/204593 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32416 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130517.pdf [firstpage_image] =>[orig_patent_app_number] => 10204593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865578 [patent_doc_number] => 20030191104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Glycosidase inhibitors and methods of synthesizing same' [patent_app_type] => new [patent_app_number] => 10/226657 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8338 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191104.pdf [firstpage_image] =>[orig_patent_app_number] => 10226657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843676 [patent_doc_number] => 20030149023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Novel compounds with analgesic effect' [patent_app_type] => new [patent_app_number] => 10/222990 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22174 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149023.pdf [firstpage_image] =>[orig_patent_app_number] => 10222990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750995 [patent_doc_number] => 20030045516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Chemokine receptor antagonists and methods of use therefor' [patent_app_type] => new [patent_app_number] => 10/217865 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 42454 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045516.pdf [firstpage_image] =>[orig_patent_app_number] => 10217865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1063025 [patent_doc_number] => 06849640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Therapeutic 1H-pyrido [4,3-b] indoles' [patent_app_type] => utility [patent_app_number] => 10/214405 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9620 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849640.pdf [firstpage_image] =>[orig_patent_app_number] => 10214405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043786 [patent_doc_number] => 06867219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => 'Antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/210781 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11217 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867219.pdf [firstpage_image] =>[orig_patent_app_number] => 10210781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385423 [patent_doc_number] => 20040016370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Functional fluorescent dyes' [patent_app_type] => new [patent_app_number] => 10/206315 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7638 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20040016370.pdf [firstpage_image] =>[orig_patent_app_number] => 10206315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053402 [patent_doc_number] => 06858733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Compounds for generating chemiluminescence with a peroxidase' [patent_app_type] => utility [patent_app_number] => 10/205050 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13659 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858733.pdf [firstpage_image] =>[orig_patent_app_number] => 10205050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814291 [patent_doc_number] => 20030073841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'New benzo [b] pyrano [3,2-h] acridin-7-one compounds' [patent_app_type] => new [patent_app_number] => 10/205566 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10444 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073841.pdf [firstpage_image] =>[orig_patent_app_number] => 10205566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818471 [patent_doc_number] => 20030069429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress' [patent_app_type] => new [patent_app_number] => 10/205997 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7219 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069429.pdf [firstpage_image] =>[orig_patent_app_number] => 10205997 [rel_patent_id] =>[rel_patent_doc_number] =>)